Literature DB >> 18290404

Prevalence of hepatitis A IgG in individuals with chronic hepatitis B infection in Babol.

M R H Roushan1, A Bijani, R Sagheb, O Jazayeri.   

Abstract

To determine the prevalence of previous hepatitis A virus (HAV) infection in people chronically infected with hepatitis B virus (HBV), we assessed the prevalence of anti-HAV IgG in 392 patients. The study was carried out in Babol, northern Islamic Republic of Iran from September 2004 to March 2005. Prevalence in those aged 10-19 years was 59.4% and was significantly lower than that in those aged 20-29 years (89.8%) and those over 29 years (97.5%). There was no significant difference in prevalence according to sex or place of residence. A significant proportion of Iranian adolescents and young adults with chronic HBV infection are at risk of contracting HAV infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18290404     DOI: 10.26719/2007.13.5.1108

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  8 in total

1.  High Prevalence of Symptomatic Hepatitis A Infection in Rural Area of Chaharmahal VA Bakhtiari Province, Iran.

Authors:  Ali Karimi; Seifollah Mortazaei; Mohammad-Taghi Moradi
Journal:  J Clin Diagn Res       Date:  2015-02-01

2.  Hepatitis A virus infection: Is it an important hazard to public health?: hazards of HAV for public health.

Authors:  Mehdi Saberifiroozi
Journal:  Hepat Mon       Date:  2011-04       Impact factor: 0.660

3.  Seroprevalence study of hepatitis A virus in Fars province, southern Iran.

Authors:  Seyed Alireza Taghavi; Mohammad Kazem Hosseini Asl; Mozaffar Talebzadeh; Ahad Eshraghian
Journal:  Hepat Mon       Date:  2011-04-01       Impact factor: 0.660

4.  Age-specific seroprevalence of anti-hepatitis a antibody among 1-30 years old population of savadkuh, mazandaran, iran with literature review.

Authors:  Mohammed Jafar Saffar; Omid Abedian; Abolghasem Ajami; Farshideh Abedian; Araz Mohammad Mirabi; Ali-Reza Khalilian; Hana Saffar
Journal:  Hepat Mon       Date:  2012-05-30       Impact factor: 0.660

5.  Prevention of hepatitis a virus infection, need to vaccinate or not?

Authors:  Pegah Karimi Elizee; Seyed-Moayed Alavian
Journal:  Int J Prev Med       Date:  2013-08

6.  Hepatitis a virus: is vaccination necessary in middle East?

Authors:  Mehdi Saberifiroozi
Journal:  Middle East J Dig Dis       Date:  2013-07

7.  Hepatitis a virus seropositivity in nurses and paramedical personnel at a university hospital in north iran.

Authors:  Masomeh Bayani; Mahmoud Sadeghi; Narges Kalantari; Abdolah Sayadmanesh
Journal:  Iran Red Crescent Med J       Date:  2013-05-05       Impact factor: 0.611

8.  Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran.

Authors:  Khashayar Hesamizadeh; Heidar Sharafi; Hossein Keyvani; Seyed Moayed Alavian; Azar Najafi-Tireh Shabankareh; Roghiyeh Sharifi Olyaie; Maryam Keshvari
Journal:  Hepat Mon       Date:  2016-01-23       Impact factor: 0.660

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.